Pancreatic Cancer section

Pancreatic Cancer News & Features

Reconstituting nab-paclitaxel

Reconstituting nab-paclitaxel

Is there a good reason to mix nab-paclitaxel (Abraxane) with warm (not cool) normal saline when reconstituting?

Pancreatic cancer risk not increased with dipeptidyl-peptidase-4 inhibitors (DPP-4i)

Pancreatic cancer risk not increased with dipeptidyl-peptidase-4 inhibitors (DPP-4i)

Findings based on comparison to sulfonylureas and thiazolidinediones

For advanced pancreatic cancer, simtuzumab not significantly more effective than placebo

For advanced pancreatic cancer, simtuzumab not significantly more effective than placebo

Gemcitabine in combination with simtuzumab 200 mg or 700 mg did not significantly increase progression-free survival.

For pancreatic cancer, chokeberry extract may enhance effectiveness of gemcitabine

For pancreatic cancer, chokeberry extract may enhance effectiveness of gemcitabine

Chokeberry, a wild berry, may improve the effectiveness of gemcitabine for the treatment of pancreatic cancer.

Existing drug offers new hope in a subtype of pancreatic cancer

Existing drug offers new hope in a subtype of pancreatic cancer

A new use for an old drug shrinks a particular type of pancreatic cancer and stops it from spreading, according to new research.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs